Abstract
Purpose
To evaluate the relationship between glaucoma diagnosis and the nailfold capillaroscopy pattern in patients with systemic sclerosis.
Methods
An observational study in a cohort of patients with SSc was conducted. Patients with at least one nailfold videocapillaroscopy and one ophthalmology examination at the same year were included. Data collected were: age, sex; type of systemic sclerosis according to the degree of skin impairment, self-reported ethnicity, disease duration, current use and dosage of systemic corticosteroid, current use and dosage of bosentan®, intraocular pressure, central corneal thickness, diagnosis of glaucoma and capillaroscopy pattern.
Results
Thirty-one patients with systemic sclerosis were enrolled, 23% had glaucoma. There was no statistically significant association between glaucoma diagnosis and the capillaroscopic pattern (p = 0.86). There was also no significant difference (p = 0.66) regarding intraocular pressure between patients with mild (13.9 ± 3.8 mmHg) and severe capillaroscopic pattern (14.4 ± 2.8 mmHg). The odds ratio of glaucoma for severe capillaroscopic pattern compared to mild was 1.6 (95% confidence interval: 0.3–9.5).
Conclusion
Up to 23% of patients with SSc have glaucoma. The high prevalence of glaucoma in SSc suggests a possible systemic vascular disturbance as the cause. However, there seems to be no significant association between the capillaroscopy pattern and glaucoma in systemic sclerosis. Further research is required to improve the understanding of glaucoma in the context of systemic sclerosis.
Similar content being viewed by others
References
Allanore Y, Avouac J, Wipff J, Kahan A (2007) New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 8:607–615
Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology 48:3–7
Gomes BA, Santhiago M, Magalhães P, Kara-Junior N, Azevedo M, Moraes HJ (2011) Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 66(3):379–385
Allanore Y, Parc C, Monnet D, Brézin A, Kahan A (2004) Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis 63(10):1276–1278
Yamamoto T, Maeda M, Sawada A, Sugiyama K, Taniguchi T, Kitazawa Y et al (1999) Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol 43(6):539–542
Kitsos G, Tsifetaki N, Gorezis S, Drosos A (2007) Glaucomatous type abnormalities in patients with systemic sclerosis. Clin Exp Rheumatol 25(2):341
Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P (2013) Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci 9(6):1107–1113
Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160
Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95
Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6(10):578–587
LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19:437–452
Ko-Ming L, Cheng TT, Cheung-Jen C (2009) Clinical applications of nailfold capillaroscopy in different rheumatic diseases. J Intern Med 20:238–247
Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 71(10):1636–1639
Leske MC (2009) Ocular perfusion pressure and glaucoma: clinical trial and epidemiological findings. Curr Opin Ophthalmol 20(2):73–78
Emre M, Orgul S, Gugleta K et al (2004) Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol 88:662–666
Tailor R, Gupta A, Herrick A, Kwartz J (2009) Ocular manifestations of scleroderma. Surv Ophthalmol 54(2):292–304
Balbir-Gurman A, Braun-Moscovici Y (2012) Scleroderma—new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol 26:13–24
Hasegawa M (2016) Biomarkers in systemic sclerosis: their potential to predict clinical courses. J Dermatol 43(1):29–38
Cabral-Marques O, Riemekasten G (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun Rev 15(7):690–694
Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L (2003) Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 76:633–640
Resch H, Karl K, Weigert G, Wolzt M, Hommer A, Schmetterer L, Garhöfer G (2009) Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci 50(1):358–363
Yorio T, Krishnamoorthy R, Prasanna G (2002) Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 11:259–270
Dismuke WM, Liang J, Overby DR, Stamer WD (2014) Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. Exp Eye Res 120:28–35
Emre S, Kayikçioğlu O, Ateş H, Cinar E, Inceoğlu N, Yargucu F, Pirildar T, Oksel F (2010) Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea 29(6):628–631
Shih CY, Graff Zivin JS, Trokel SL et al (2004) Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 122:1270–1275
Serup L, Serup J, Hagdrup H (1984) Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh) 62(1):69–74
Gomes BA, Santhiago M, Kara-Junior N et al (2011) Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea 30(10):1125–1128
Gomes BA, Santhiago MR, Kara-Junior N, de Azevedo MN, Moraes HV Jr (2015) Assessment of central corneal thickness in different subtypes of systemic sclerosis. Ocul Immunol Inflamm 11:1–6
Atik SS, Koc F, Sari SA, Yurdakul NS, Ozmen M, Akar S (2015) Anterior segment parameters and eyelids in systemic sclerosis. Int Ophthalmol 36(4):577–583
Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979–982
Iudici M, van der Goes MC, Valentini G, Bijlsma JW (2013) Glucocorticoids in systemic sclerosis: weighing the benefits and risks—a systematic review. Clin Exp Rheumatol 31(2 Suppl 76):157–165
Gomes BF, Moraes HV Jr, Kara-Junior N, de Azevedo MN, de Lima FBF, Santhiago MR (2014) Intraocular pressure in chronic users of low-dose oral corticosteroids for connective tissue disease. Can J Ophthalmol 49(4):363–366
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gomes, B.F., Souza, R., Valadão, T. et al. Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?. Int Ophthalmol 38, 251–256 (2018). https://doi.org/10.1007/s10792-017-0454-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-017-0454-1